Omri Amirav-Drory
Listed on 4 Form D filings across 4+ issuers
· Director, Executive Officer
Associated issuers
- NFX SL Advantage I, L.P. CIK 2109603 · CA
- NFX SST Advantage I, L.P. CIK 2109068 · CA
- TwoStep Therapeutics, Inc. CIK 2015273 · CA
- ImmuneBridge Inc. CIK 1960306 · CA
Filings (4)
-
NFX SL Advantage I, L.P.D · Mar 3, 2026 · CA · Pooled Investment Fund$14.6MView filing →
-
NFX SST Advantage I, L.P.D · Feb 26, 2026 · CA · Pooled Investment Fund$4.1MView filing →
-
TwoStep Therapeutics, Inc.D · Jan 20, 2026 · CA · Other$62.2MView filing →
-
ImmuneBridge Inc.D · Apr 2, 2025 · CA · Biotechnology$7.1MView filing →